perm filename MYCIN.DIA[AM,DBL] blob sn#581010 filedate 1981-04-28 generic text, type C, neo UTF8
COMMENT āŠ—   VALID 00003 PAGES
C REC  PAGE   DESCRIPTION
C00001 00001
C00002 00002	16-Apr-81 23:20:24-PST,14455000000000001
C00006 00003	April 16, 1981 10:46PM in <MYCIN>MYCIN.SAV10310 by SHORTLIFFE
C00026 ENDMK
CāŠ—;
16-Apr-81 23:20:24-PST,14455;000000000001
Mail-from: ARPANET site SUMEX-AIM rcvd at 16-Apr-81 2319-PST
Date: 16 Apr 1981 2317-PST
From: Shortliffe@SUMEX-AIM
Subject: what MYCIN says
To:   csd.lenat@SCORE

Doug,
	Appended is a MYCIN run on Nicole's case.  You'll note that the
program thinks that a viral syndrome is most likely and did not even
recommend therapy pending a repeat LP in 6-8 hours or so.
	I asked a few additional questions at the end, though, to show
you why the treatment of ampicillin with chloramphenicol has been chosen.
The organism that one worries about most in a child Nicole's age is
hemophilus influenzae;  I've listed the 3 applicable rules that show
why hemophilus is considered particularly likely.  Ampicillin also covers
for the other common organisms, and it once was used routinely as a single
agent in situations such as this, but because about 3% of childhood 
hemophilus is resistant to ampicillin, the second choice drug (chlorampheni-
col) is routinely given with the ampicillin until the sensitivities of the
organism are known.  It's a conservative precaution but generally considered
reasonable in a potentially serious infection such as meningitis.
	As for why the Stanford physicians started treatment but MYCIN
didn't, this reflects the fact that MYCIN knows nothing about infections
at other sites.  The house staff were pushed to start antibiotics by the
high likelihood of urinary tract infection as much as by the rather mild
abnormalities in the CSF.  I believe you said that the intern indicated that
in similar circumstances it might have been reasonable to wait and do a
repeat LP if there weren't reason to start antibiotics to cover for possible
infections at other sites.
	I'm not sure you're interested in all this analysis, but I was
concerned that the MYCIN run might raise more questions than it answers
unless I also provide a little explanation.
	Hope Nicole is markedly improved by the morning.
	Regards,
	   Ted

----------------------------
April 16, 1981 10:46PM in <MYCIN>MYCIN.SAV;10310 by SHORTLIFFE

--------------------------------------------------------------------------------

16-Apr-81 22:46:12

   --------PATIENT-1--------
   1) Patient's name:
   ** Nicole L
   2) Age:
   ** 4 MONTHS
   3) Sex:
   ** F
   4) Race:
   ** CAUC
=CAUCASIAN
   5) Are there any cultures for Nicole L which may be related to the
      present illness, and from which organisms have been grown successfully
      in the microbiology laboratory?
   ** N
   6) Are there any pending cultures for Nicole L?
   ** Y

      --------CULTURE-1--------
      7) From what site was the specimen for CULTURE-1 taken?
      ** CSF
      8) Please give the date and time when the pending csf culture
         (CULTURE-1) was obtained. (mo/da/yr time)
      ** 4/16/81 3PM
      9) Was a smear examined at the time that the specimen for the pending
         csf culture (CULTURE-1) was obtained?
      ** Y
      10) Were any organisms seen on the smear of the specimen submitted as
          the pending csf culture (CULTURE-1)?
      ** N
   11) Are there any other pending cultures?
   ** N
   12) Have there been negative (as opposed to pending) cultures obtained
       from Nicole L which may be relevant to the present illness?
   ** N
   13) Do you suspect Nicole L may have an infection at a site from which
       you have not obtained culture specimens?
   ** N
   14) Is Nicole L currently receiving therapy with any antimicrobial
       agent?
   ** N
   15) During the present illness, has Nicole L been treated with an
       antimicrobial agent which is no longer being administered?
   ** N
[Considering organisms (other than those isolated from cultures) which might
be present...]
   16) Has Nicole L recently had symptoms of persistent headache or other
       abnormal neurologic symptoms (dizziness, lethargy, etc.)?
   ** Y
   17) Has Nicole L recently had objective evidence of abnormal
       neurologic signs (nuchal rigidity, coma, seizures, etc.) documented by
       physician observation or examination?
   ** Y

The CSF cultures will be considered to be associated with MENINGITIS.
   18) Please give the date on which clinical evidence (symptoms, signs, or
       laboratory tests) of the meningitis first appeared.
   ** 4/15/81 6PM
   19) Does Nicole L have an abnormal chest X-ray?
   ** UNK
   20) Does Nicole L have one or more of the following risk factors for
       tb: a) positive intermediate strength PPD, b) history of close contact
       with a person with active tb, c) a household member with a past
       history of active tb, d) apical scarring on chest xray, e) history of
       granulomas on biopsy of liver, lymph node, or other organs.?
   ** N
   21) Does Nicole L have any cutaneous lesions or rash on physical
       examination?
   ** N
   22) Does Nicole L have evidence of ocular nerve dysfunction?
   ** N
   23) Is Nicole L a compromised host (e.g. alcoholic, sickle-cell-
       disease, immunosuppressed)?
   ** N
   24) For how many days has Nicole L had abnormal neurologic signs?
   ** 1
   25) For how many days has Nicole L had neurologic symptoms?
   ** 1
   26) Has Nicole L had recent evidence of tender or enlarged salivary
       glands?
   ** N
   27) Has Nicole L been exposed to any contagious disease recently (e.g.
       meningococcal disease, mumps) ?
   ** UNK
   28) What is the protein value (mg/100cc) in the CSF?
   ** 22
   29) What is the total WBC count of the CSF?
   ** 18
   30) What percent of the WBCs in the CSF were polys?
   ** 74
   31) What is the glucose value (milligrams percent) in the CSF?
   ** 94
   32) What is the simultaneous blood glucose?
   ** 79
   33) Do you know the results of a recent CBC of Nicole L?
   ** Y
   34) What was Nicole L's peripheral white count (in thousands)?
   ** 24.8
   35) Has Nicole L had any injury or insult to, or defect in the central-
       nervous-system (excluding neurosurgery)?
   ** N
   36) Has Nicole L ever undergone any type of surgery?
   ** N
   37) Does Nicole L live in a crowded environment?
   ** N
   38) Is the meningitis a hospital-acquired infection?
   ** N
   39) Is Nicole L's clinical history consistent with EPIGLOTTITIS?
   ** N
   40) Is Nicole L's clinical history consistent with OTITIS-MEDIA?
   ** N
   41) Is Nicole L a burn patient?
   ** N

I have found evidence (RULE564) that treatment should cover for Virus causing
     meningitis.
   42) Does Nicole L have focal neurological signs?
   ** N
     [Determining which drugs are desirable for use against the Virus...]


   My therapy recommendations will be designed to treat for organisms
that  either are very likely  or, although less likely,  would have a
significant effect  on therapy selection if they  were present. It is
important  to  cover  for the  following  probable  infection(s)  and
associated organism(s):


INFECTION-1 is MENINGITIS

  +     ...   VIRUS [from clinical evidence only]   Supportive therapy.

     Please repeat the LP in 8 - 24 hours for cultures (bacterial, fungal,
     Tb, and viral), cells, and chemistries.


       Please ask questions now. When you are finished and want to 
   begin a new consultation or sign off the terminal, enter the word 
   STOP.

Type HELP for the list of question options.

** HOW DO YOU TREAT FOR HEMOPHILUS INFLUENZAE CAUSING MENINGITIS?

    For treatment of HEMOPHILUS-INFLUENZAE in MENINGITIS
    The drugs of choice (ranked by relative efficacy, assuming sensitivity)
are:
    1st choice:
        AMPICILLIN
    2nd choice:
        CHLORAMPHENICOL
    3rd choice:
        CARBENICILLIN
        TETRACYCLINE
        ERYTHROMYCIN
        CEPHALOTHIN
    Duration of therapy: Treat for at least 5 afebrile days or for a minimum
        of 10 days.


** HOW DO YOU DECIDE TO COVER FOR HEMOPHILUS INFLUENZAE?
The following rules conclude about:
     the likelihood that Hemophilus-influenzae is one of the organisms (other
          than those seen on cultures or smears) which might be causing the
          infection

562, 554, 549, 548, 547, 546, 507, 341, 73

The parameters most frequently used in these rules are:
     the infection which requires therapy
     the diagnoses which are consistent with the patient's clinical history
     the type of the infection
     the stain of the organism
     the morphology of the organism
     whether the patient has a head injury defect
     the age of the patient
     whether a smear of the culture was examined
     whether organisms were seen on the stain of the culture

Would you like a summary of ALL the parameters used by these rules?   ** NO

Which of the rules do you wish to see?
      ** 554 507 341

RULE554
-------
[This rule applies to organisms, and is tried in order to find out about the
     organisms (other than those seen on cultures or smears) which might be
     causing the infection]

  If:  1) The infection which requires therapy is meningitis,
       2) The stain of the organism is not Gramneg,
       3) The morphology of the organism is not rod,
       4) The patient does not have a head injury defect, and
       5) The age of the patient is known
  Then:  The organisms (other than those seen on cultures or smears) which
            might be causing the infection is as follows:
         If the age of the patient is:
         a) less than 10 days then: e.coli (.4), klebsiella-pneumoniae (.3),
            streptococcus-group-b (.4),
         b) between 10 days and 1 month then: e.coli (.4), klebsiella-
            pneumoniae (.3), streptococcus-group-b (.4),
         c) between 1 month and 2 months then: e.coli (.3), streptococcus-
            group-b (.4), listeria (.3);
**-->>   d) between 2 months and 1 year then: diplococcus-pneumoniae (.3),
            hemophilus-influenzae (.4), neisseria-meningitidis (.3),
         e) between 1 year and 5 years then: diplococcus-pneumoniae (.3),
            hemophilus-influenzae (.4), neisseria-meningitidis (.3),
         f) between 5 years and 15 years then: diplococcus-pneumoniae (.4),
            hemophilus-influenzae (.3), neisseria-meningitidis (.4),
         g) between 15 years and 55 years then: diplococcus-pneumoniae (.4),
            neisseria-meningitidis (.4),
         h) greater or equal to 55 years then: staphylococcus-coag-pos (.3),
            diplococcus-pneumoniae (.4),
  Author: Yu


RULE507
-------
[This rule applies to pending cultures and suspected infections, and is tried
     in order to find out about the organisms (other than those seen on
     cultures or smears) which might be causing the infection]

  If:  1) The infection which requires therapy is meningitis,
       2) A: A smear of the culture was not examined, or
          B: Organisms were not seen on the stain of the culture,
       3) The type of the infection is bacterial,
       4) The patient does not have a head injury defect, and
       5) The age of the patient is known
  Then:  The organisms (other than those seen on cultures or smears) which
            might be causing the infection is as follows:
         If the age of the patient is:
         a) less than 10 days then: e.coli (.75), klebsiella-pneumoniae (.5),
            streptococcus-group-b (.75),
         b) between 10 days and 1 month then: e.coli (.75), klebsiella-
            pneumoniae (.5), streptococcus-group-b (.75),
         c) between 1 month and 2 months then: e.coli (.75), streptococcus-
            group-b (.75), listeria (.4);
**-->    d) between 2 months and 1 year then: diplococcus-pneumoniae (.41),
            streptococcus-group-b (.4), hemophilus-influenzae (.75),
            neisseria-meningitidis (.4),
         e) between 1 year and 5 years then: diplococcus-pneumoniae (.41),
            hemophilus-influenzae (.75), neisseria-meningitidis (.4),
         f) between 5 years and 15 years then: diplococcus-pneumoniae (.75),
            hemophilus-influenzae (.73), neisseria-meningitidis (.74),
         g) between 15 years and 55 years then: diplococcus-pneumoniae (.75),
            neisseria-meningitidis (.74),
         h) greater or equal to 55 years then: staphylococcus-coag-pos (.4),
            streptococcus-species (.4), diplococcus-pneumoniae (.75),
  Author: Yu


RULE341
-------
[This rule applies to suspected infections, and is tried in order to find out
     about the organisms (other than those seen on cultures or smears) which
     might be causing the infection]

  If:  1) The infection which requires therapy is meningitis,
       2) The age of the patient is known,
       3) The type of the infection is bacterial, and
       4) The patient does not have a head injury defect
  Then:  The organisms (other than those seen on cultures or smears) which
            might be causing the infection is as follows:
         If the age of the patient is:
         a) less than 10 days then: e.coli (.75), klebsiella-pneumoniae (.5),
            streptococcus-group-b (.75),
         b) between 10 days and 1 month then: e.coli (.75), klebsiella-
            pneumoniae (.5), streptococcus-group-b (.75),
         c) between 1 month and 2 months then: e.coli (.75), streptococcus-
            group-b (.75), listeria (.4);
**-->    d) between 2 months and 1 year then: diplococcus-pneumoniae (.41),
            streptococcus-group-b (.4), hemophilus-influenzae (.75),
            neisseria-meningitidis (.4),
         e) between 1 year and 5 years then: diplococcus-pneumoniae (.41),
            hemophilus-influenzae (.75), neisseria-meningitidis (.4),
         f) between 5 years and 15 years then: diplococcus-pneumoniae (.75),
            hemophilus-influenzae (.73), neisseria-meningitidis (.74),
         g) between 15 years and 55 years then: diplococcus-pneumoniae (.75),
            neisseria-meningitidis (.74),
         h) greater or equal to 55 years then: staphylococcus-coag-pos (.4),
            streptococcus-species (.4), diplococcus-pneumoniae (.75),
  Author: "Scott"


** STOP


Do you wish advice on another patient?
** NO

-------